Safety and efficacy of glucagon-like peptide 1 receptor agonists in patients With cirrhosis.
| dc.contributor.author | Morris, Sean M | |
| dc.contributor.author | Armstrong, Matthew J | |
| dc.contributor.author | Newsome, Philip N | |
| dc.date.accessioned | 2024-09-19T14:28:22Z | |
| dc.date.available | 2024-09-19T14:28:22Z | |
| dc.date.issued | 2021-09-22 | |
| dc.identifier.citation | Morris SM, Armstrong MJ, Newsome PN. Safety and Efficacy of Glucagon-like Peptide 1 Receptor Agonists in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2022 Jun;20(6):1220-1222. doi: 10.1016/j.cgh.2021.09.023. Epub 2021 Sep 22 | en_US |
| dc.identifier.issn | 1542-3565 | |
| dc.identifier.eissn | 1542-7714 | |
| dc.identifier.doi | 10.1016/j.cgh.2021.09.023 | |
| dc.identifier.pmid | 34560279 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14200/5806 | |
| dc.description.abstract | No abstract available | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | W.B. Saunders | en_US |
| dc.relation.url | http://www.sciencedirect.com/science/journal/15423565 | en_US |
| dc.subject | Gastroenterology | en_US |
| dc.title | Safety and efficacy of glucagon-like peptide 1 receptor agonists in patients With cirrhosis. | en_US |
| dc.type | Other | en_US |
| dc.source.journaltitle | Clinical Gastroenterology and Hepatology | en_US |
| dc.source.volume | 20 | |
| dc.source.issue | 6 | |
| dc.source.beginpage | 1220 | |
| dc.source.endpage | 1222 | |
| dc.source.country | United Kingdom | |
| dc.source.country | United States | |
| rioxxterms.version | NA | en_US |
| dc.contributor.trustauthor | Armstrong, Matthew J | |
| dc.contributor.department | Liver | en_US |
| dc.contributor.role | Medical and Dental | en_US |
| oa.grant.openaccess | na | en_US |
Files in this item
Name:
Publisher version